Back to Gastroenterology
Gastroenterologyv1978Evidence-Based

Maddrey's Discriminant Function for Alcoholic Hepatitis

Predicts prognosis and steroid benefit in alcoholic hepatitis

Clinical Input Parameters

seconds
Range: 8 — 120 seconds
seconds
Range: 8 — 20 seconds
mg/dL
Range: 0.1 — 50 mg/dL
Clinical Assessment
Awaiting Parameters
maddrey score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Maddrey's Discriminant Function for Alcoholic Hepatitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Maddrey's DF = 4.6 × (Patient's PT - Control PT) + Total Bilirubin

Clinical Pearls & Practice Notes

  • Developed in 1978 by Maddrey et al. following a randomized controlled trial
  • First established clinical prognostic score for alcoholic hepatitis
  • Score ≥32 indicates severe alcoholic hepatitis with poor prognosis
  • Score <32 indicates mild to moderate disease with 90% 30-day survival without steroids
  • Patients with score ≥32 may benefit from corticosteroid therapy
  • Should be used in conjunction with contraindications assessment for steroids
  • Less useful for long-term prognosis prediction
  • MELD score may be more accurate for mortality prediction in some studies
  • Often combined with Lille score to assess treatment response
  • Control PT is typically 11-13 seconds in most laboratories
  • Requires exclusion of other causes of hepatitis and acute liver failure
  • Consider liver biopsy in patients with severe disease (score ≥32)

Evidence & Literature Citations

  1. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978 Aug;75(2):193-9. PMID: 352788.
  2. Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 1989 May 1;110(9):685-90. doi: 10.7326/0003-4819-110-9-685.
  3. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007 Jun;45(6):1348-54. doi: 10.1002/hep.21607.

Score Interpretation Ranges

Mild to Moderate0 – 31 pts

Good prognosis, steroid therapy not indicated

Severe32 – 1000 pts

Poor prognosis, consider steroid therapy

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.